WallStSmart

Diebold Nixdorf, Incorporated (DBD)vsServiceNow Inc (NOW)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

ServiceNow Inc generates 280% more annual revenue ($14.73B vs $3.87B). NOW leads profitability with a 11.3% profit margin vs 2.9%. DBD trades at a lower P/E of 21.5x. DBD earns a higher WallStSmart Score of 54/100 (C-).

DBD

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 5.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.57

NOW

Hold

47

out of 100

Grade: D+

Growth: 6.7Profit: 5.5Value: 6.0Quality: 4.0
Piotroski: 1/9Altman Z: 1.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DBD.

NOWUndervalued (+77.4%)

Margin of Safety

+77.4%

Fair Value

$619.62

Current Price

$148.57

$471.05 discount

UndervaluedFair: $619.62Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DBD2 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

EPS GrowthGrowth
34.2%8/10

Earnings expanding 34.2% YoY

NOW2 strengths · Avg: 8.5/10
Market CapQuality
$142.64B9/10

Large-cap with strong market position

Revenue GrowthGrowth
24.0%8/10

Revenue surging 24.0% year-over-year

Areas to Watch

DBD4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.7%4/10

1.7% revenue growth

Altman Z-ScoreHealth
1.574/10

Distress zone — elevated risk

Profit MarginProfitability
2.9%3/10

2.9% margin — thin

Debt/EquityHealth
1.143/10

Elevated debt levels

NOW4 concerns · Avg: 3.5/10
Price/BookValuation
12.3x4/10

Trading at 12.3x book value

Altman Z-ScoreHealth
1.654/10

Distress zone — elevated risk

Operating MarginProfitability
4.1%3/10

Operating margin of 4.1%

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : DBD

The strongest argument for DBD centers on Price/Book, EPS Growth.

Bull Case : NOW

The strongest argument for NOW centers on Market Cap, Revenue Growth. Revenue growth of 24.0% demonstrates continued momentum. PEG of 1.01 suggests the stock is reasonably priced for its growth.

Bear Case : DBD

The primary concerns for DBD are Revenue Growth, Altman Z-Score, Profit Margin. Thin 2.9% margins leave little buffer for downturns.

Bear Case : NOW

The primary concerns for NOW are Price/Book, Altman Z-Score, Operating Margin. A P/E of 86.2x leaves little room for execution misses.

Key Dynamics to Monitor

DBD profiles as a value stock while NOW is a growth play — different risk/reward profiles.

DBD carries more volatility with a beta of 1.19 — expect wider price swings.

NOW is growing revenue faster at 24.0% — sustainability is the question.

NOW generates stronger free cash flow (473M), providing more financial flexibility.

Bottom Line

DBD scores higher overall (54/100 vs 47/100). NOW offers better value entry with a 77.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diebold Nixdorf, Incorporated

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico and Latin America. The company is headquartered in North Canton, Ohio.

ServiceNow Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

ServiceNow is an American software company based in Santa Clara, California that develops a cloud computing platform to help companies manage digital workflows for enterprise operations.

Want to dig deeper into these stocks?